The site of the Media Sphera Publishers contains materials intended solely for healthcare professionals.
By closing this message, you confirm that you are a certified medical professional or a student of a medical educational institution.

Berezovskiĭ D.P.

GBOU VPO "Rostovskiĭ gosudarstvennyĭ meditsinskiĭ universitet"

Varavva T.A.

NII biologii Iuzhnogo federal'nogo universiteta, Rostov-na-Donu;
kspertno-kriminalisti­cheskiĭ tsentr Glavnogo upravleniia MVD Rossii po Rostovskoĭ oblasti

Faleeva T.G.

Kafedra sudebnoĭ meditsiny s kursom pravovedeniia Rostovskogo gosudarstvennogo meditsinskogo universiteta;
Filial #2 111-go FGKU "Gosudarstvennyĭ tsentr sudebno-meditsinskikh i kriminalisticheskikh kspertiz" Minoborony Rossii, Rostov-na-Donu

Pigolkin Yu.I.

Sechenov’s First Moscow State Medical University, Moscow, Russia

Kornienko I.V.

FGAOU "Iuzhnyĭ federal'nyĭ universitet", Rostov-na-Donu

Forensic medical evaluation of hereditary predisposition to thrombophilia in the case of thrombotic complications of a mechanical injury

Authors:

Berezovskiĭ D.P., Varavva T.A., Faleeva T.G., Pigolkin Yu.I., Kornienko I.V.

More about the authors

Journal: Forensic Medical Expertise. 2014;57(1): 22‑25

Read: 825 times


To cite this article:

Berezovskiĭ DP, Varavva TA, Faleeva TG, Pigolkin YuI, Kornienko IV. Forensic medical evaluation of hereditary predisposition to thrombophilia in the case of thrombotic complications of a mechanical injury. Forensic Medical Expertise. 2014;57(1):22‑25. (In Russ.)

Recommended articles:
Iatrogenic exte­rnal iliac artery injury following inguinal hernia repair. Russian Journal of Cardiology and Cardiovascular Surgery. 2024;(6):695-698
Traumatic inju­ries of the rectum and anus in childhood. Piro­gov Russian Journal of Surgery. 2025;(8):62-66

References:

  1. Kopenkin S.S.  Profilakytika venoznykh tromboembolicheskykh oslozhneniy v travmatologii I ortopedii [The prevention of venous thromboembolic complications in traumatology and orthopedics]. Consilium Medicum (surgery) 2005; 7: 1: 15-20.
  2. Pigolkin Yu.I., Bogomolova I.N.  Primenenie printsipov dokazatel'noy meditsiny v kachestve kriteriev poleznosti novykh metodov issledovaniya v ekspertnoy praktike [Application of the principles of evidence-based medicine as the criteria for the practicability of the research methods in the expert practice]. Sud-med. ekspert. , 2004; 6; 3 - 6.
  3. Reitsma P.H., Rosendaal F.R. Past and future of genetic research in thrombosis. J Thrombol Haemost 2007; 5: 1: 264-269.
  4. Zubairov D.M.  Vrozhdennaya trombofiliya [Congenital thrombophilia]. Sorov. Obrazov. Zhurn., 1997; 8; 33 - 37.
  5. Geerts W., Pineo G., Heit J., Bergqvist D., Lassen M.R., Colwell C.W., Ray J.G. Prevention of venous tromboembolism. the Seventh ACCP Consensus Conference on Antithrombotic and Thrombolytic Therapy. Chest 2004; 126: 338-400.
  6. Tashkinov N.V., Kuz'min  I.I., Shreiberg K.A., Babikhin A.V.  Faktory riska I profilaktika tromboembolicheskikh oslozhneniy pri totatl'nom endoprotezirovanii tazobedrennogo sustava [Risk Factors of thromboembolic complications in the case of the hip endoprosthetic treatment]. Dal'nevost. Med. zhurn., 2009; 2; 33 -- 35.
  7. Rosendaal F.R., Siscovick D.S., Schwartz S.M., Psaty B.M., Raghunathan T.E., Vos H.L. A common prothrombin variant (20210 G to A) increases the risk of myocardial infarction in young women. Blood 1997; 90: 5: 1747-1750.
  8. Doix S., Mahrousseh M., Jolak M., Laurent Y., Lorenzini J.L., Binquet C., Zeller M., Cottin Y., Wolf J.E. Factor V Leiden and myocardial infarction: a case, review of the literature with a metaanalysis. Ann Cardiol Angeiol (Paris) 2003; 52: 3: 143-149.
  9. Kosokabe T., Okumura K., Sone T., Kondo J., Tsuboi H., Mukawa H., Tomida T., Suzuki T., Kamiya H., Matsui H., Hayakawa T. Relation of a Common Methylenetetrahydrofolate Reductase Mutation and Plasma Homocysteine With Intimal Hyperplasia After Coronary Stenting. Circulation 2001; 103: 2048-2054.
  10. Suzuki J., Ogawa M., Muto S., Itai A., Hirata Y., Isobe M., Nagai R. Effects of specific chemical suppressors of plasminogen activator inhibitor-1 in cardiovascular diseases. Exp Opin Inv Drugs 2011; 20: 255-264.

Email Confirmation

An email was sent to test@gmail.com with a confirmation link. Follow the link from the letter to complete the registration on the site.

Email Confirmation

We use cооkies to improve the performance of the site. By staying on our site, you agree to the terms of use of cооkies. To view our Privacy and Cookie Policy, please. click here.